Good morning :)
Switch to
Place Order

Sanofi India Ltd

SANOFI
Health CarePharmaceuticals
SmallcapWith a market cap of ₹13,233 cr, stock is ranked 296
Low RiskStock is 1.06x as volatile as Nifty
5,739.350.11% (-6.50)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹13,233 cr, stock is ranked 296
Low RiskStock is 1.06x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
14.015.958.53%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.854.380.88%

Forecast & RatingsDetailed Forecast 

88%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.

Brands

Sanofi India

Pharmaceutical company

Brands

Sanofi India

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2018201920202021+2.86+3.16+2.99+3.52+0.38+0.41+0.48+0.94
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Postal Ballot 
Announced OnNov 25, 2022

Pursuant to our letter dated 3rd November 2022, we wish to inform you that the Company is seeking approval of Members of the Company through an Ordinary Resolution for appointment of Ms. Annapurna Das as Non-Executive (Non-Independent) Director of the Company with effect from 3rd November 2022, through Ordinary Resolution, as set out in the Postal Ballot notice dated 3rd November 2022, by way of electronic voting (¬タリremote e-voting¬タル). | Download

Pursuant to our letter dated 3rd November 2022, we wish to inform you that the Company is seeking approval of Members of the Company through an Ordinary Resolution for appointment of Ms. Annapurna Das as Non-Executive (Non-Independent) Director of the Company with effect from 3rd November 2022, through Ordinary Resolution, as set out in the Postal Ballot notice dated 3rd November 2022, by way of electronic voting (¬タリremote e-voting¬タル). | Download

Loss of share certificate 
Announced OnNov 18, 2022

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate | Download

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate | Download

Cash Dividend 
Ex. DateAug 5, 2022

Special • Div/Share: ₹ 193

See all events